BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND B2M, P61769, 567, ENSG00000166710 AND Prognosis
4 results:

  • 1. A novel circRNA, circNUP98, a potential biomarker, acted as an oncogene via the miR-567/ PRDX3 axis in renal cell carcinoma.
    Yu R; Yao J; Ren Y
    J Cell Mol Med; 2020 Sep; 24(17):10177-10188. PubMed ID: 32729669
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Development and validation of an individualized DNA repair-related gene signature in localized clear cell renal cell carcinoma.
    Xiong Y; Qi Y; Lin W; Bai Q; Liu L; Guo J
    World J Urol; 2021 Apr; 39(4):1203-1210. PubMed ID: 32458095
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A large-scale transcriptome analysis identified ELANE and PRTN3 as novel methylation prognostic signatures for clear cell renal cell carcinoma.
    Wei Z; Wu B; Wang L; Zhang J
    J Cell Physiol; 2020 Mar; 235(3):2582-2589. PubMed ID: 31490025
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Cellular B-2 microglobulin expression as a prognostic indicator in renal cell carcinoma.
    Levin I; Kuperman O; Goldstein J; Neumann L; Segal S; Kaneti J; Lismer L; Machpud A; Klein B
    Acta Oncol; 1991; 30(8):941-5. PubMed ID: 1777246
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.